The ROE as of November 2024 (TTM) for OpGen, Inc. (OPGN) is 120.18%

According to OpGen, Inc.’s latest financial reports and current stock price. The company's current ROE is 120.18%. This represents a change of 5.34% compared to the average of 114.09% of the last 4 quarters.

OpGen, Inc. (OPGN) Historical ROE (quarterly & annually)

How has OPGN ROE performed in the past?

The mean historical ROE of OpGen, Inc. over the last ten years is -293.05%. The current 120.18% ROE has changed -141.01% with respect to the historical average. Over the past ten years (40 quarters), OPGN's ROE was at its highest in in the September 2024 quarter at 299.07%. The ROE was at its lowest in in the March 2017 quarter at -898.45%.

OpGen, Inc. (OPGN) ROE by Quarter and Year

Discovering the peaks and valleys of OpGen, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

OpGen, Inc. (OPGN) Average ROE

How has OPGN ROE performed in the past?

The current ROE of OpGen, Inc. (OPGN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

OpGen, Inc. (OPGN) ROE vs. Peers

How is OPGN’s ROE compared to its peers?

OpGen, Inc.’s ROE is greater than Bone Biologics Corporation (-221.43%), greater than NanoVibronix, Inc. (-101.17%), greater than Bluejay Diagnostics, Inc. (-155.68%), greater than Vivos Therapeutics, Inc. (-335.03%), greater than Tivic Health Systems, Inc. (-201.30%), greater than Heart Test Laboratories, Inc. (-144.10%), greater than NeuroMetrix, Inc. (-42.56%), greater than ReShape Lifesciences Inc. (-179.83%), greater than Inspira Technologies Oxy B.H.N. Ltd. (-134.16%), greater than Sight Sciences, Inc. (-47.28%), greater than STRATA Skin Sciences, Inc. (-91.63%), greater than NeuroPace, Inc. (-205.41%), less than Vapotherm, Inc. (86.17%), greater than Talis Biomedical Corporation (-79.73%), greater than Nuwellis, Inc. (-26663.64%), less than Nemaura Medical Inc. (37.24%), greater than Movano Inc. (-345.78%), greater than INVO Bioscience, Inc. (-1073.76%), greater than enVVeno Medical Corporation (-48.73%),

Build a custom stock screener for OpGen, Inc. (OPGN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like OpGen, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

OpGen, Inc. (OPGN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like OpGen, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.